Navigation Links
4 Johns Hopkins researchers named AAAS Fellows
Date:11/25/2013

The American Association for the Advancement of Science has announced that the Johns Hopkins School of Medicine's L. Mario Amzel, Ph.D., of the Department of Biophysics and Biophysical Chemistry; Philip Cole, M.D., Ph.D., of the Department of Pharmacology and Molecular Sciences; Valina Dawson, Ph.D., of the Department of Neurology; and the Johns Hopkins University's Stephen Murray, Ph.D., of the Henry A. Rowland Department of Physics and Astronomy are among 388 new fellows from around the world. AAAS fellows are elected by their peers and honored for their scientifically or socially distinguished efforts to advance science or its applications.

The names of the awardees were published in the "AAAS News and Notes" section of Science on Nov. 29. The newly elected fellows will be awarded a certificate and a rosette pin during the AAAS Fellows Forum at the 2014 AAAS annual meeting in Chicago on Saturday, Feb. 15.

L. Mario Amzel, Ph.D., is a professor and director of the Department of Biophysics and Biophysical Chemistry. He was elected for his distinguished contributions to the understanding of protein structure and function, especially as is relevant to the immune system, infectious disease and cancer. His research team studies the chemistry of reactions carried out by enzymes. By determining the three-dimensional structures of these proteins and the conditions that affect their efficiency, they are able to figure out the roles they play in the body. Some of the information they gather is being used to design drugs targeting the enzymes.

Philip Cole, M.D., Ph.D., is the E.K. Marshall and Thomas H. Maren Professor and director of the Department of Pharmacology and Molecular Sciences. He is being recognized for his distinguished contributions to the field of chemical biology, particularly the development and applications of chemical approaches to understanding protein structure and functions. His laboratory studies the way in which the addition of small chemical groups affects the functioning of proteins. His work has broad implications for everything from cellular signaling to gene regulation to metabolism.

Valina Dawson, Ph.D., is a professor in the Department of Neurology and director of the Neuroregeneration Program in the Institute for Cell Engineering. She was elected for discoveries regarding nerve cell death and survival, especially what her team learned about molecular chain reactions that govern both. These reactions involve the signaling molecules nitric oxide, poly (ADP-ribose) polymerase and other proteins that contribute to Parkinson's disease. Her work is helping us to understand why nerve cells die due to disease or trauma and what we can do to boost the body's ability to replace them.

Stephen Murray, Ph.D., is a Research Professor in the Department of Physics and Astronomy, where he teaches and carries out research in high-energy astrophysics and X-ray astronomy. He was elected for innovative contributions to high-resolution X-ray imaging spectroscopy, and for founding the NASA Astrophysics Data System that has transformed the way we access information. The data system, used by virtually all astronomers and astrophysicists worldwide, has provided free access to the published literature in their field. As the lead researcher in charge of developing X-ray technologies for several of NASA's space mission projects, Murray helped develop X-ray imaging detectors that were successfully flown on several space missions. He is currently working to design tools for studying the small bodies of the outer solar system.


'/>"/>

Contact: Catherine Kolf
ckolf@jhmi.edu
443-287-2251
Johns Hopkins Medicine
Source:Eurekalert  

Related biology news :

1. Johns Hopkins And Belgian research center to expand health care applications for silicon nanotech
2. 3 Johns Hopkins researchers recognized for medical inventions
3. NREL and Johnson Matthey announce 5-year collaboration on biofuels
4. 3 Johns Hopkins researchers named AAAS Fellows
5. The Johns Hopkins Center for Inherited Disease Research receives $101 million
6. Johns Hopkins researchers link 2 biological risk factors for schizophrenia
7. Johns Hopkins researchers uncover genes at fault for cystic fibrosis-related intestinal obstruction
8. Genetic predictors of postpartum depression uncovered by Hopkins researchers
9. Researchers use nanoscale patches to sensitize targeted cell receptors
10. 2 Cleveland Clinic researchers honored for contribution to science
11. Researchers describe 1 mechanism that favors rejection in transplantation of porcine cartilage in humans
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
4 Johns Hopkins researchers named AAAS Fellows
(Date:2/8/2017)... NEW YORK , Feb. 7, 2017 Report ... ... and should reach $11.4 billion by 2021, growing at a ... Report Includes - An overview of the global markets for ... from 2015, estimates for 2016, and projections of compound annual ...
(Date:2/7/2017)... 2017   MedNet Solutions , an innovative SaaS-based ... clinical research, is pleased to announce that the latest ... highly flexible and award winning eClinical solution, is now ... is a proven Software-as-a-Service (SaaS) clinical research technology ... but also delivers an entire suite of eClinical tools ...
(Date:2/6/2017)... According to Acuity Market Intelligence, ongoing ... to continue to embrace biometric and digital identification ... Border Control (ABC) eGates and 1436 Automated Passport ... 163 ports of entry across the globe. Deployments ... combined CAGR of 37%. APC Kiosks reached 75% ...
Breaking Biology News(10 mins):
(Date:2/24/2017)... ... 24, 2017 , ... Delpor, Inc. (Delpor), a biotechnology company focused on drug ... Mental Health (NIMH) for the further advancement of the company’s 3-month olanzapine product ( ... expected to deliver therapeutic levels of olanzapine for a period of 3 months., “We ...
(Date:2/24/2017)... , Feb. 24, 2017 Provectus Biopharmaceuticals, ... the "Company"), a clinical-stage oncology and dermatology biopharmaceutical ... deadline to participate in its previously announced rights ... of shares of common stock and Series C ... of listed warrants. As previously ...
(Date:2/24/2017)... 2017 Symic Bio, a biopharmaceutical company focused ... of therapeutics, announced today the completion of enrollment for ... disease. The trial will evaluate the safety and efficacy ... reduction of restenosis following angioplasty. "We,re ... SB-030," said Nathan Bachtell , M.D., Chief Medical ...
(Date:2/24/2017)... Cord Blood Corporation (NYSE: CO ) ("CCBC" ... collection, laboratory testing, hematopoietic stem cell processing and stem ... for the third quarter and first nine months of ... Third Quarter of Fiscal 2017 Highlights ... by 18.6% to RMB200.9 million ($28.9 million). ...
Breaking Biology Technology: